Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Hemispherx Biopharma Inc

+ Add to Watchlist

HEB:US

0.2199 USD 0.0001 0.05%

As of 20:04:05 ET on 01/30/2015.

Company Profile for Hemispherx Biopharma Inc (HEB)

Hemispherx Biopharma, Inc. is a biopharmaceutical company that focuses on the development of nucleic acids to enhance the natural anti-viral defense systems of the human body. The Company's lead product, Ampligen, is undergoing clinical trials for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Contact Information

Hemispherx Biopharma Inc

1617 JFK Boulevard
Suite 660
Philadelphia, PA 19103
United States
Phone: 1-215-988-0080
Fax: 1-215-988-1739

Key Executives for Hemispherx Biopharma Inc (HEB)

William A CarterChairman/Pres/CEOThomas K EquelsVice Chair/CFO/Secy/Gen Cnsl
David R StrayerChief Medical Ofcr/Medical DirAdam PascaleChief Accounting Officer
Wayne S SpringateSenior VP:OperationsRalph Christopher CavalliVP:Quality Control

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil